Defibrillators, Cardiac Monitors Boost Cardiac Science Q407 Revenues

January 8, 2007 - Cardiac Science Corp. expects 2007 fourth quarter revenue to total approximately $50 million, representing growth of approximately 28 percent compared with the fourth quarter of 2006, thanks to strong growth in revenue from its defibrillation products and cardiac monitoring line. For the year, revenue is expected to exceed $181 million, representing year-over-year growth of approximately 17 percent compared to 2006, according to preliminary revenue results for the fourth quarter ended December 31, 2007. “Defibrillation revenue continues to benefit from solid demand for AEDs both domestically and internationally and we realized meaningful revenue during the fourth quarter from sales of our recently-introduced crash cart defibrillator, consistent with our earlier expectations," said John Hinson, president and chief executive officer. Fourth quarter 2007 revenue estimates are preliminary. The Company expects to announce its full financial results for the fourth quarter 2007 in late February 2008. For more information: www.cardiacscience.com